=== PAGE 5 ===

COMPLETE PAGE ANALYSIS:
--------------------------------------------------
David Shechter
Amgen Inc.
BLA 125031 MA 1706

Please refer to MA 1706 in addition to the BLA number in all future correspondence relating
to this particular matter. All correspondence should include a subject line that clearly
identifies the submission as a Response to Untitled Letter.

                                                          Sincerely,

                                      {See appended electronic signature page}

                                      Rebecca Falter, PharmD, BCACP
                                      Regulatory Review Officer
                                      Division of Advertising & Promotion Review 1
                                      Office of Prescription Drug Promotion

                                      {See appended electronic signature page}

                                      Susannah O'Donnell, MPH, RAC
                                      Team Leader
                                      Division of Advertising & Promotion Review 1
                                      Office of Prescription Drug Promotion
Page 5
Reference ID: 4822416
